查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
2017149

外科网片市场：依产品类型、固定方法、原料类型、应用和最终用户划分－2026-2032年全球市场预测

Surgical Mesh Market by Product Type, Fixation Technique, Source Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，外科网片市场价值将达到 27.6 亿美元，到 2026 年将成长至 29.9 亿美元，到 2032 年将达到 47.9 亿美元，复合年增长率为 8.16%。

主要市场统计数据
基准年 2025 27.6亿美元
预计年份：2026年 29.9亿美元
预测年份 2032 47.9亿美元
复合年增长率 (%) 8.16%

详细概述外科网片生态系统，将现代医学中的材料创新、临床期望和采购压力连结起来。

外科网片仍然是重组和修復手术的关键基础，其材料性能、固定可靠性和临床疗效相互交织，共同决定患者的康復轨迹。过去十年，临床医生和製造商一直在应对由聚合物化学创新、生物相容性整合和技术改进所塑造的不断变化的市场环境。同时，监管和报销压力也调整了产品的市场推广曲线。因此，相关人员必须综合解读临床证据和价值链的实际情况，从而优先考虑那些既能保证安全性又能带来价值的投资。

材料科学的突破、固定技术的创新、监管的加强以及供应的韧性正在重新定义整个外科网片行业的竞争重点。

外科网片产业正经历一场变革性的转变，这场变革正在重塑产品研发的重点和临床应用模式。可吸收聚合物和混合结构的进步正在重新定义外科医生如何在短期支撑和长期组织整合之间取得平衡，而表面工程和孔隙率的改进则旨在减少感染和粘连。因此，医疗设备的差异化越来越依赖材料的创新性，以及在功能性结果和併发症减少方面可证实的优势。

评估美国关税政策如何重塑外科网片整个价值链的采购决策、製造在地化和采购惯例。

美国关税的实施对外科网片产业的相关人员产生了多方面的影响，包括采购、生产策略和临床应用。关税带来的成本压力促使买家和製造商重新评估其筹资策略，并加快对近岸外包和国内生产能力的关注，以降低进口关税风险并提高库存应对力。随着采购团队努力稳定总到岸成本，产品规格、包装和物流正受到更严格的审查，以寻找能够抵消额外关税的效率提升机会。

透过多层次細項分析，明确了决定产品策略和采用的因素，例如材料、固定方法、供应商、临床应用和最终用户。

深入的市场区隔揭示了外科网片市场中附加价值与风险交会的领域。根据产品类型，可吸收网片和不可吸收网片的差异决定了不同的研发重点。可吸收网片（包括Polyglactin和聚乙醇酸乙醇酸网片等亚型）的创新着重于可预测的吸收特性和组织重塑，而不可吸收网片（例如膨体聚四氟乙烯网片、聚酯网片和聚丙烯网片）的改进则着重于长期机械支撑和耐久性。这些基于材料的差异会影响临床方案、植入选择标准和术后后续观察策略。

全部区域在临床实践、法律规范和采购行为方面存在细微的区域差异，因此需要製定量身定制的商业化策略。

区域趋势对外科网片产品的研发、行销和分销有显着影响。在美洲，市场活动通常着重于临床证据的累积、报销方案的调整以及对微创解决方案的需求，采购流程则由综合医疗网络和大规模医院集团主导，他们优先考虑产品的价值和供应稳定性。同时，在欧洲、中东和非洲（EMEA）地区，监管协调和多元化的医疗资金筹措模式正在影响产品的推广路径，这要求製造商调整实证材料和定价策略，以满足各国不同的需求。

竞争差异化如何根植于临床证据、製造弹性、伙伴关係生态系统以及以外科医生为中心的价值提案。

主要企业之间的竞争格局日益取决于它们能否将临床证据、生产灵活性和策略伙伴关係关係整合为一个连贯的价值提案。投资长期疗效研究和完善的上市后监测的市场领导往往能赢得外科界和采购委员会的更强信任。同时，灵活的中小型企业和Start-Ups正透过专注于新型材料、差异化固定係统或针对特定手术的解决方案，开闢利基市场，以应对持续存在的临床挑战。

为製造商和供应商提供切实可行的策略措施，以增强在不断变化的外科网片领域的韧性、临床应用和价值实现。

产业领导者应优先考虑一系列切实可行的策略，将市场洞察转化为持久的竞争优势。首先，投资建立多元化的製造地，将国内生产能力与值得信赖的区域合作伙伴结合，以应对关税风险并缩短前置作业时间。其次，加速建立医疗设备特性与以病人为中心的治疗结果之间的关联证据，无论手术类型如何，从而加强采购谈判和与支付方的沟通。第三，开发模组化产品线，使临床医生能够在可吸收和不可吸收材料之间进行选择，并选择适合手术偏好和医疗机构能力的固定方法。

一个严谨的多方面研究框架，结合了对临床医生的访谈、采购负责人的观点以及综合文献，得出了基于证据的、可操作的结论。

本报告的研究结合了对临床医生、采购经理和行业专家的访谈，以及对同行评审的临床文献、监管申报文件和製造商文件的系统性回顾。主要研究包括与多学科外科医生进行半结构式访谈，以了解真实的临床模式，以及与供应链和采购专家进行讨论，以了解营运限制和决策标准。次要研究提供了材料科学进展、更新的监管指南和已发表的临床结果研究方面的背景资讯。

对影响外科网片市场产品策略、临床应用和营运韧性的相互关联的因素进行明确的整合。

总之，外科网片领域正处于一个转折点，材料创新、固定技术进步、监管趋严以及地缘政治压力交织在一起，迫使企业重新定义策略重点。能够透过高品质证据证明临床价值、调整生产和筹资策略以降低关税和供应风险、并提供以临床医生为中心的解决方案（从而简化选择并改善治疗效果）的企业，才能最终取得成功。研发、监管、临床和销售团队之间的跨职能协作对于将技术优势转化为永续的市场差异化至关重要。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 外科网片市场：依产品类型划分

  • 吸水网
    • Polyglactin网
    • 聚乙醇酸网
  • 不吸水网
    • 膨胀聚四氟乙烯网
    • 聚酯网布
    • 聚丙烯网

第九章：以固定方式分類的外科网片市场

  • 使用黏合剂进行固定
    • 黏合剂
    • 合成黏合剂
  • 缝合固定
    • 连续缝合
    • 间断缝合
  • 使用褶皱进行修復
    • 吸水黏性材料
    • 不吸水黏性材料

第十章：依原料类型分類的外科网片市场

  • 生物起源
  • 合成

第十一章 外科网片市场：依应用领域划分

  • 乳房重建
  • 疝气修补术
  • 骨盆器官脱垂
  • 重组手术
  • 应力性尿失禁
  • 创伤/外科性创伤

第十二章 外科网片市场：依最终用户划分

  • 门诊手术中心
  • 诊所
  • 医院

第十三章 外科网片市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 外科网片市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 外科网片市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国外科网片市场

第十七章：中国外科网片市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • 3M Company
  • Angiologica BMSrl
  • Aran Biomedical
  • ASSUT Europe SpA
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Betatech Medical
  • BG Medical LLC
  • BioCer Entwicklungs-GmbH
  • Boston Scientific Corporation
  • Coloplast Corp.
  • Cousin Biotech SAS
  • Deep Blue Medical Advances, Inc.
  • Dipromed Srl
  • Dolphin Sutures
  • Integra LifeSciences Corporation
  • Johnson & Johnson Services, Inc
  • KLS Martin Group
  • Lotus Surgicals
  • Medtronic PLC
  • Novus Scientific AB
  • Tela Bio, Inc.
  • THT Bio-Science
  • Vitrex Medical A/S
  • WL Gore & Associates, Inc.
Product Code: MRR-0355054AC4C7

The Surgical Mesh Market was valued at USD 2.76 billion in 2025 and is projected to grow to USD 2.99 billion in 2026, with a CAGR of 8.16%, reaching USD 4.79 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.76 billion
Estimated Year [2026] USD 2.99 billion
Forecast Year [2032] USD 4.79 billion
CAGR (%) 8.16%

A nuanced overview of the surgical mesh ecosystem that connects material innovation, clinical practice expectations, and procurement pressures in contemporary care

Surgical mesh continues to be a cornerstone in reconstructive and reparative surgery, where material performance, fixation reliability, and clinical outcomes intersect to determine patient recovery trajectories. Over the past decade, clinicians and manufacturers have navigated an evolving landscape shaped by innovations in polymer chemistry, biologic integrations, and technique refinement, all while regulatory scrutiny and reimbursement pressures recalibrate the adoption curve. Consequently, stakeholders must interpret clinical evidence alongside supply chain realities to prioritize investments that deliver both safety and value.

In parallel, patient expectations for minimally invasive procedures and reduced complication rates amplify the importance of device design and fixation strategy. Health systems increasingly demand robust real-world evidence and cost-effectiveness data that demonstrate improved patient-reported outcomes and shorter lengths of stay. Therefore, a modern market perspective extends beyond device attributes to encompass lifecycle performance, training requirements for surgical teams, and alignment with evolving clinical pathways.

This introduction frames the subsequent analysis by emphasizing the interplay between materials science, clinical practice, and macroeconomic forces, setting the stage for a detailed examination of transformative shifts, tariff impacts, segmentation nuances, and regional dynamics that will guide strategic decisions for manufacturers, providers, and investors.

How material science breakthroughs, fixation innovations, regulatory tightening, and supply resilience are redefining competitive priorities across the surgical mesh sector

The surgical mesh landscape is undergoing transformative shifts that are reshaping product development priorities and clinical adoption patterns. Advances in absorbable polymers and hybrid constructs are redefining how surgeons balance short-term support with long-term tissue integration, while improvements in surface engineering and porosity are targeting reductions in infection and adhesion. As a result, device differentiation increasingly hinges on demonstrable benefits in functional outcomes and complication mitigation rather than on material novelty alone.

Concurrently, fixation approaches are evolving from traditional sutures and tacks toward adhesive-based and minimally invasive techniques that prioritize operative efficiency and reduced patient discomfort. This shift is reinforced by a growing emphasis on standardized training and procedure-specific guidance, which together support more consistent outcomes across care settings. In addition, regulatory landscapes have tightened, prompting manufacturers to invest in more rigorous clinical evidence generation and post-market surveillance that, in turn, inform purchasing decisions and payer discussions.

Supply chain resilience and regional manufacturing footprints are also rising in strategic importance amid geopolitical uncertainties and trade policy shifts. Collectively, these dynamics are accelerating consolidation and collaborative partnerships between device innovators, contract manufacturers, and clinical research organizations to ensure agility and compliance while sustaining innovation pipelines.

Assessment of how U.S. tariff policy has reshaped sourcing decisions, manufacturing localization, and procurement practices across the surgical mesh value chain

The application of tariffs in the United States has created multifaceted implications across procurement, manufacturing strategy, and clinical adoption for surgical mesh stakeholders. Tariff-driven cost pressures have prompted purchasers and manufacturers to re-evaluate sourcing strategies, accelerating interest in nearshoring and domestic production capabilities to reduce exposure to import levies and to improve inventory responsiveness. As procurement teams seek to stabilize total landed costs, product specifications and packaging logistics have garnered closer scrutiny to identify efficiency opportunities that offset incremental duties.

Manufacturers facing higher import costs have adopted a range of responses, including localizing certain manufacturing steps, renegotiating supplier contracts, and optimizing component sourcing to preserve competitive pricing. These adjustments have practical downstream effects: supply continuity becomes a procurement priority, contractual terms incorporate more robust contingency provisions, and product portfolios are assessed for margin resilience under altered cost structures. Hospital purchasing groups and ambulatory centers are increasingly integrating tariff sensitivity into vendor evaluations, emphasizing suppliers that demonstrate transparent cost modeling and supply chain redundancy.

Clinicians and hospital administrators must also consider the indirect clinical impact of tariff-induced shifts, since changes in availability, lead times, or product selection can influence procedure planning and inventory management. Consequently, organizations are aligning cross-functional teams-supply chain, clinical leadership, and finance-to navigate the operational implications while maintaining care quality and patient safety.

A layered segmentation analysis clarifying material, fixation, source, clinical application, and end user drivers that determine product strategy and adoption

Insightful segmentation reveals where incremental value and risk converge within the surgical mesh market. Based on product type, the distinction between absorbable mesh and non-absorbable mesh underpins divergent development priorities: absorbable mesh innovations, which include polyglactin mesh and polyglycolic mesh subtypes, emphasize predictable resorption profiles and tissue remodeling, whereas non-absorbable mesh variants such as expanded polytetrafluoroethylene mesh, polyester mesh, and polypropylene mesh focus on long-term mechanical support and durability. These material-based differences cascade into clinical protocols, implant selection criteria, and postoperative surveillance strategies.

Fixation technique segmentation further clarifies adoption dynamics, with adhesive-based fixation, suture-based fixation, and tack-based fixation each presenting distinct trade-offs. Adhesive-based approaches split into biological adhesives and synthetic adhesives, offering varying biocompatibility and handling characteristics, while suture-based fixation differentiates continuous sutures and interrupted sutures in terms of procedural time and tissue tension control. Tack-based fixation, categorized by absorbable tacks and non-absorbable tacks, raises considerations around long-term foreign body presence and potential late complications, which affect surgeon preference and patient counseling.

Source type segmentation, distinguishing biological and synthetic origins, intersects with regulatory pathways and reimbursement discussions, and influences clinician perceptions of infection risk and integration. Application-based segmentation identifies areas of clinical focus-breast reconstruction, hernia repair, pelvic organ prolapse, reconstructive surgery, stress urinary incontinence, and traumatic or surgical wounds-each with unique performance and evidence requirements. End user segmentation across ambulatory surgical centers, clinics, and hospitals shapes purchasing behaviors, contract size, and inventory management, thereby informing go-to-market tactics and training investments.

Regional nuances in clinical practice, regulatory frameworks, and procurement behavior that require tailored commercialization strategies across the Americas, EMEA, and Asia-Pacific

Regional dynamics significantly influence how surgical mesh products are developed, marketed, and distributed. In the Americas, market activity often centers on clinical evidence generation, reimbursement alignment, and demand for minimally invasive solutions, with procurement processes driven by integrated delivery networks and large hospital groups that prioritize value and supply stability. Conversely, in Europe, Middle East & Africa, regulatory harmonization efforts and diverse healthcare funding models shape adoption pathways, prompting manufacturers to tailor evidence dossiers and pricing strategies to meet heterogeneous national requirements.

Asia-Pacific markets are characterized by rapid infrastructure investment, growing surgeon proficiency in advanced techniques, and an appetite for cost-competitive innovations. These markets also present opportunities for local manufacturing partnerships and technology transfer agreements that can accelerate market entry while addressing regional price sensitivity. Each region's distinct combination of clinical practice patterns, regulatory expectations, and procurement mechanisms necessitates regionally calibrated commercialization plans that balance global product platforms with locally relevant evidence and distribution strategies.

Across regions, collaboration between manufacturers and local clinical leaders supports more effective training, adoption, and post-market data collection, enabling companies to adapt product messaging and support services in alignment with regional priorities and care delivery models.

How competitive differentiation is anchored in clinical evidence, manufacturing agility, partnership ecosystems, and surgeon-focused value propositions

Competitive dynamics among key companies are increasingly defined by their ability to integrate clinical evidence, manufacturing agility, and strategic partnerships into coherent value propositions. Market leaders that invest in longitudinal outcomes research and robust post-market surveillance tend to command stronger trust among surgical communities and procurement committees. At the same time, agile smaller players and startups are carving niches by focusing on novel materials, differentiated fixation systems, or procedure-specific solutions that address persistent clinical challenges.

Strategic collaboration is prevalent, with alliances spanning co-development agreements, contract manufacturing partnerships, and clinical research collaborations that accelerate time-to-evidence. Many organizations are also exploring adjacent capabilities such as surgical instrumentation, training platforms, and digital solutions for tracking outcomes to strengthen adoption and customer retention. Operational excellence in quality systems and regulatory compliance bolsters market access, while transparent supply chain practices and localized sourcing strategies mitigate exposure to trade disruptions.

For competitors, sustained differentiation will depend on aligning product performance with clear economic and clinical value propositions, supported by accessible education for clinicians and robust customer service models that reduce barriers to adoption across diverse care settings.

Practical strategic moves for manufacturers and providers to strengthen resilience, clinical adoption, and value realization in a shifting surgical mesh environment

Industry leaders should prioritize a set of actionable strategies to translate market insights into durable competitive advantage. First, invest in diversified manufacturing footprints that combine domestic capabilities with trusted regional partners to manage tariff exposure and to shorten lead times. Second, accelerate evidence generation that links device characteristics to patient-centered outcomes across procedure types, thereby strengthening procurement conversations and payer engagement. Third, develop modular product lines that allow clinicians to select between absorbable and non-absorbable options and to choose fixation methods that align with procedural preferences and site capabilities.

Leaders must also commit to enhanced clinician education programs that embed best practices for fixation and mesh selection, supported by simulation and proctoring that reduce variability in outcomes. From a commercial perspective, pricing and contracting strategies should reflect total cost of care rather than unit price alone, and account for regional reimbursement landscapes. Finally, pursue digital and service-based offerings-such as outcomes tracking platforms and training curricula-that create stickiness with customers and provide ongoing real-world data to inform iterative product improvements.

Collectively, these measures will enable organizations to respond to regulatory intensification, supply chain volatility, and evolving clinical expectations while maintaining a focus on sustainable growth and patient safety.

A rigorous, multi-source research framework combining clinician interviews, procurement perspectives, and literature synthesis to ensure evidence-driven and actionable conclusions

The research underpinning this report combined primary engagement with clinicians, procurement leaders, and industry experts alongside systematic review of peer-reviewed clinical literature, regulatory filings, and manufacturer documentation. Primary research included semi-structured interviews with surgeons across multiple specialties to capture real-world practice patterns, as well as discussions with supply chain and procurement professionals to understand operational constraints and decision criteria. Secondary research provided contextual grounding in material science developments, regulatory guidance updates, and published clinical outcome studies.

Data synthesis relied on triangulation across multiple sources to validate thematic findings, with particular attention to consistency between clinical preferences, purchasing behavior, and manufacturer strategies. Segmentation mapping was applied to align product attributes, fixation techniques, source types, clinical applications, and end user dynamics into an integrated framework that supports actionable recommendations. Quality assurance steps included cross-validation by subject matter experts and iterative review cycles to ensure clarity and practical relevance.

The methodology recognizes inherent limitations: evolving regulatory positions and emerging clinical evidence may alter specific interpretations over time, and regional heterogeneity means that local market intelligence should supplement this analysis when making operational decisions.

Conclusive synthesis of the interconnected forces shaping product strategy, clinical adoption, and operational resilience within the surgical mesh market

In conclusion, the surgical mesh sector is at an inflection point where material innovation, fixation technique evolution, regulatory rigor, and geopolitical pressures converge to redefine strategic priorities. Success will favor organizations that can demonstrate clinical value through high-quality evidence, adapt manufacturing and sourcing strategies to mitigate tariff and supply risks, and deliver clinician-centric solutions that simplify choice and improve outcomes. Cross-functional alignment between R&D, regulatory, clinical affairs, and commercial teams will be essential to translate technical advantages into sustainable market differentiation.

Looking ahead, stakeholders should prepare for continued emphasis on patient-reported outcomes, real-world evidence, and cost-effective care pathways that support adoption across care settings. By focusing on resilient operations, targeted clinical investments, and partnerships that bridge technical and commercial capabilities, organizations can position themselves to meet the dual imperatives of safety and value while capturing opportunities in an increasingly sophisticated and demanding market environment.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Surgical Mesh Market, by Product Type

  • 8.1. Absorbable Mesh
    • 8.1.1. Polyglactin Mesh
    • 8.1.2. Polyglycolic Mesh
  • 8.2. Non-Absorbable Mesh
    • 8.2.1. Expanded Polytetrafluoroethylene Mesh
    • 8.2.2. Polyester Mesh
    • 8.2.3. Polypropylene Mesh

9. Surgical Mesh Market, by Fixation Technique

  • 9.1. Adhesive-Based Fixation
    • 9.1.1. Biological Adhesives
    • 9.1.2. Synthetic Adhesives
  • 9.2. Suture-Based Fixation
    • 9.2.1. Continuous Sutures
    • 9.2.2. Interrupted Sutures
  • 9.3. Tack-Based Fixation
    • 9.3.1. Absorbable Tacks
    • 9.3.2. Non-Absorbable Tacks

10. Surgical Mesh Market, by Source Type

  • 10.1. Biological
  • 10.2. Synthetic

11. Surgical Mesh Market, by Application

  • 11.1. Breast Reconstruction
  • 11.2. Hernia Repair
  • 11.3. Pelvic Organ Prolapse
  • 11.4. Reconstructive Surgery
  • 11.5. Stress Urinary Incontinence
  • 11.6. Traumatic/Surgical Wounds

12. Surgical Mesh Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Clinics
  • 12.3. Hospitals

13. Surgical Mesh Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Surgical Mesh Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Surgical Mesh Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Surgical Mesh Market

17. China Surgical Mesh Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. 3M Company
  • 18.6. Angiologica B.M. S.r.l.
  • 18.7. Aran Biomedical
  • 18.8. ASSUT Europe S.p.A.
  • 18.9. B. Braun Melsungen AG
  • 18.10. Becton, Dickinson and Company
  • 18.11. Betatech Medical
  • 18.12. BG Medical LLC
  • 18.13. BioCer Entwicklungs-GmbH
  • 18.14. Boston Scientific Corporation
  • 18.15. Coloplast Corp.
  • 18.16. Cousin Biotech SAS
  • 18.17. Deep Blue Medical Advances, Inc.
  • 18.18. Dipromed Srl
  • 18.19. Dolphin Sutures
  • 18.20. Integra LifeSciences Corporation
  • 18.21. Johnson & Johnson Services, Inc
  • 18.22. KLS Martin Group
  • 18.23. Lotus Surgicals
  • 18.24. Medtronic PLC
  • 18.25. Novus Scientific AB
  • 18.26. Tela Bio, Inc.
  • 18.27. THT Bio-Science
  • 18.28. Vitrex Medical A/S
  • 18.29. W. L. Gore & Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL SURGICAL MESH MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SURGICAL MESH MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL SURGICAL MESH MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL SURGICAL MESH MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL SURGICAL MESH MARKET SIZE, BY FIXATION TECHNIQUE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SURGICAL MESH MARKET SIZE, BY SOURCE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL SURGICAL MESH MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SURGICAL MESH MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL SURGICAL MESH MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SURGICAL MESH MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL SURGICAL MESH MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES SURGICAL MESH MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA SURGICAL MESH MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL SURGICAL MESH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL SURGICAL MESH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL SURGICAL MESH MARKET SIZE, BY ABSORBABLE MESH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL SURGICAL MESH MARKET SIZE, BY ABSORBABLE MESH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL SURGICAL MESH MARKET SIZE, BY ABSORBABLE MESH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL SURGICAL MESH MARKET SIZE, BY ABSORBABLE MESH, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL SURGICAL MESH MARKET SIZE, BY POLYGLACTIN MESH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL SURGICAL MESH MARKET SIZE, BY POLYGLACTIN MESH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL SURGICAL MESH MARKET SIZE, BY POLYGLACTIN MESH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL SURGICAL MESH MARKET SIZE, BY POLYGLYCOLIC MESH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL SURGICAL MESH MARKET SIZE, BY POLYGLYCOLIC MESH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL SURGICAL MESH MARKET SIZE, BY POLYGLYCOLIC MESH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SURGICAL MESH MARKET SIZE, BY NON-ABSORBABLE MESH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SURGICAL MESH MARKET SIZE, BY NON-ABSORBABLE MESH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SURGICAL MESH MARKET SIZE, BY NON-ABSORBABLE MESH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SURGICAL MESH MARKET SIZE, BY NON-ABSORBABLE MESH, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SURGICAL MESH MARKET SIZE, BY EXPANDED POLYTETRAFLUOROETHYLENE MESH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SURGICAL MESH MARKET SIZE, BY EXPANDED POLYTETRAFLUOROETHYLENE MESH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL SURGICAL MESH MARKET SIZE, BY EXPANDED POLYTETRAFLUOROETHYLENE MESH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL SURGICAL MESH MARKET SIZE, BY POLYESTER MESH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL SURGICAL MESH MARKET SIZE, BY POLYESTER MESH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SURGICAL MESH MARKET SIZE, BY POLYESTER MESH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SURGICAL MESH MARKET SIZE, BY POLYPROPYLENE MESH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL SURGICAL MESH MARKET SIZE, BY POLYPROPYLENE MESH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL SURGICAL MESH MARKET SIZE, BY POLYPROPYLENE MESH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SURGICAL MESH MARKET SIZE, BY FIXATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SURGICAL MESH MARKET SIZE, BY ADHESIVE-BASED FIXATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SURGICAL MESH MARKET SIZE, BY ADHESIVE-BASED FIXATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SURGICAL MESH MARKET SIZE, BY ADHESIVE-BASED FIXATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL SURGICAL MESH MARKET SIZE, BY ADHESIVE-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL SURGICAL MESH MARKET SIZE, BY BIOLOGICAL ADHESIVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL SURGICAL MESH MARKET SIZE, BY BIOLOGICAL ADHESIVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL SURGICAL MESH MARKET SIZE, BY BIOLOGICAL ADHESIVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL SURGICAL MESH MARKET SIZE, BY SYNTHETIC ADHESIVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL SURGICAL MESH MARKET SIZE, BY SYNTHETIC ADHESIVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL SURGICAL MESH MARKET SIZE, BY SYNTHETIC ADHESIVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SURGICAL MESH MARKET SIZE, BY SUTURE-BASED FIXATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL SURGICAL MESH MARKET SIZE, BY SUTURE-BASED FIXATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SURGICAL MESH MARKET SIZE, BY SUTURE-BASED FIXATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SURGICAL MESH MARKET SIZE, BY SUTURE-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SURGICAL MESH MARKET SIZE, BY CONTINUOUS SUTURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL SURGICAL MESH MARKET SIZE, BY CONTINUOUS SUTURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL SURGICAL MESH MARKET SIZE, BY CONTINUOUS SUTURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL SURGICAL MESH MARKET SIZE, BY INTERRUPTED SUTURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL SURGICAL MESH MARKET SIZE, BY INTERRUPTED SUTURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL SURGICAL MESH MARKET SIZE, BY INTERRUPTED SUTURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL SURGICAL MESH MARKET SIZE, BY TACK-BASED FIXATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL SURGICAL MESH MARKET SIZE, BY TACK-BASED FIXATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL SURGICAL MESH MARKET SIZE, BY TACK-BASED FIXATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL SURGICAL MESH MARKET SIZE, BY TACK-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL SURGICAL MESH MARKET SIZE, BY ABSORBABLE TACKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL SURGICAL MESH MARKET SIZE, BY ABSORBABLE TACKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL SURGICAL MESH MARKET SIZE, BY ABSORBABLE TACKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL SURGICAL MESH MARKET SIZE, BY NON-ABSORBABLE TACKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL SURGICAL MESH MARKET SIZE, BY NON-ABSORBABLE TACKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL SURGICAL MESH MARKET SIZE, BY NON-ABSORBABLE TACKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL SURGICAL MESH MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL SURGICAL MESH MARKET SIZE, BY BIOLOGICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL SURGICAL MESH MARKET SIZE, BY BIOLOGICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL SURGICAL MESH MARKET SIZE, BY BIOLOGICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL SURGICAL MESH MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL SURGICAL MESH MARKET SIZE, BY SYNTHETIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL SURGICAL MESH MARKET SIZE, BY SYNTHETIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL SURGICAL MESH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL SURGICAL MESH MARKET SIZE, BY BREAST RECONSTRUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL SURGICAL MESH MARKET SIZE, BY BREAST RECONSTRUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL SURGICAL MESH MARKET SIZE, BY BREAST RECONSTRUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL SURGICAL MESH MARKET SIZE, BY HERNIA REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL SURGICAL MESH MARKET SIZE, BY HERNIA REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL SURGICAL MESH MARKET SIZE, BY HERNIA REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL SURGICAL MESH MARKET SIZE, BY PELVIC ORGAN PROLAPSE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL SURGICAL MESH MARKET SIZE, BY PELVIC ORGAN PROLAPSE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL SURGICAL MESH MARKET SIZE, BY PELVIC ORGAN PROLAPSE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL SURGICAL MESH MARKET SIZE, BY RECONSTRUCTIVE SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL SURGICAL MESH MARKET SIZE, BY RECONSTRUCTIVE SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL SURGICAL MESH MARKET SIZE, BY RECONSTRUCTIVE SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL SURGICAL MESH MARKET SIZE, BY STRESS URINARY INCONTINENCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL SURGICAL MESH MARKET SIZE, BY STRESS URINARY INCONTINENCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL SURGICAL MESH MARKET SIZE, BY STRESS URINARY INCONTINENCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL SURGICAL MESH MARKET SIZE, BY TRAUMATIC/SURGICAL WOUNDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL SURGICAL MESH MARKET SIZE, BY TRAUMATIC/SURGICAL WOUNDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL SURGICAL MESH MARKET SIZE, BY TRAUMATIC/SURGICAL WOUNDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL SURGICAL MESH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL SURGICAL MESH MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL SURGICAL MESH MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL SURGICAL MESH MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL SURGICAL MESH MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL SURGICAL MESH MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL SURGICAL MESH MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL SURGICAL MESH MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL SURGICAL MESH MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL SURGICAL MESH MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL SURGICAL MESH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS SURGICAL MESH MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS SURGICAL MESH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS SURGICAL MESH MARKET SIZE, BY ABSORBABLE MESH, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS SURGICAL MESH MARKET SIZE, BY NON-ABSORBABLE MESH, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS SURGICAL MESH MARKET SIZE, BY FIXATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS SURGICAL MESH MARKET SIZE, BY ADHESIVE-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS SURGICAL MESH MARKET SIZE, BY SUTURE-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS SURGICAL MESH MARKET SIZE, BY TACK-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS SURGICAL MESH MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS SURGICAL MESH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS SURGICAL MESH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA SURGICAL MESH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA SURGICAL MESH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA SURGICAL MESH MARKET SIZE, BY ABSORBABLE MESH, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA SURGICAL MESH MARKET SIZE, BY NON-ABSORBABLE MESH, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA SURGICAL MESH MARKET SIZE, BY FIXATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA SURGICAL MESH MARKET SIZE, BY ADHESIVE-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA SURGICAL MESH MARKET SIZE, BY SUTURE-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA SURGICAL MESH MARKET SIZE, BY TACK-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA SURGICAL MESH MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA SURGICAL MESH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA SURGICAL MESH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA SURGICAL MESH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA SURGICAL MESH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA SURGICAL MESH MARKET SIZE, BY ABSORBABLE MESH, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA SURGICAL MESH MARKET SIZE, BY NON-ABSORBABLE MESH, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA SURGICAL MESH MARKET SIZE, BY FIXATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA SURGICAL MESH MARKET SIZE, BY ADHESIVE-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA SURGICAL MESH MARKET SIZE, BY SUTURE-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA SURGICAL MESH MARKET SIZE, BY TACK-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA SURGICAL MESH MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA SURGICAL MESH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA SURGICAL MESH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA SURGICAL MESH MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA SURGICAL MESH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA SURGICAL MESH MARKET SIZE, BY ABSORBABLE MESH, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA SURGICAL MESH MARKET SIZE, BY NON-ABSORBABLE MESH, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA SURGICAL MESH MARKET SIZE, BY FIXATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA SURGICAL MESH MARKET SIZE, BY ADHESIVE-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA SURGICAL MESH MARKET SIZE, BY SUTURE-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA SURGICAL MESH MARKET SIZE, BY TACK-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA SURGICAL MESH MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA SURGICAL MESH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA SURGICAL MESH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE SURGICAL MESH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE SURGICAL MESH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE SURGICAL MESH MARKET SIZE, BY ABSORBABLE MESH, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE SURGICAL MESH MARKET SIZE, BY NON-ABSORBABLE MESH, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE SURGICAL MESH MARKET SIZE, BY FIXATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE SURGICAL MESH MARKET SIZE, BY ADHESIVE-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE SURGICAL MESH MARKET SIZE, BY SUTURE-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE SURGICAL MESH MARKET SIZE, BY TACK-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE SURGICAL MESH MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE SURGICAL MESH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE SURGICAL MESH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST SURGICAL MESH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST SURGICAL MESH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST SURGICAL MESH MARKET SIZE, BY ABSORBABLE MESH, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST SURGICAL MESH MARKET SIZE, BY NON-ABSORBABLE MESH, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST SURGICAL MESH MARKET SIZE, BY FIXATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST SURGICAL MESH MARKET SIZE, BY ADHESIVE-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST SURGICAL MESH MARKET SIZE, BY SUTURE-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST SURGICAL MESH MARKET SIZE, BY TACK-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 157. MIDDLE EAST SURGICAL MESH MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST SURGICAL MESH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST SURGICAL MESH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA SURGICAL MESH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA SURGICAL MESH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA SURGICAL MESH MARKET SIZE, BY ABSORBABLE MESH, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA SURGICAL MESH MARKET SIZE, BY NON-ABSORBABLE MESH, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA SURGICAL MESH MARKET SIZE, BY FIXATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA SURGICAL MESH MARKET SIZE, BY ADHESIVE-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA SURGICAL MESH MARKET SIZE, BY SUTURE-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA SURGICAL MESH MARKET SIZE, BY TACK-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 168. AFRICA SURGICAL MESH MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. AFRICA SURGICAL MESH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 170. AFRICA SURGICAL MESH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC SURGICAL MESH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC SURGICAL MESH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC SURGICAL MESH MARKET SIZE, BY ABSORBABLE MESH, 2018-2032 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC SURGICAL MESH MARKET SIZE, BY NON-ABSORBABLE MESH, 2018-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC SURGICAL MESH MARKET SIZE, BY FIXATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 176. ASIA-PACIFIC SURGICAL MESH MARKET SIZE, BY ADHESIVE-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC SURGICAL MESH MARKET SIZE, BY SUTURE-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC SURGICAL MESH MARKET SIZE, BY TACK-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 179. ASIA-PACIFIC SURGICAL MESH MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC SURGICAL MESH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC SURGICAL MESH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 182. GLOBAL SURGICAL MESH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN SURGICAL MESH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN SURGICAL MESH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. ASEAN SURGICAL MESH MARKET SIZE, BY ABSORBABLE MESH, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN SURGICAL MESH MARKET SIZE, BY NON-ABSORBABLE MESH, 2018-2032 (USD MILLION)
  • TABLE 187. ASEAN SURGICAL MESH MARKET SIZE, BY FIXATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 188. ASEAN SURGICAL MESH MARKET SIZE, BY ADHESIVE-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN SURGICAL MESH MARKET SIZE, BY SUTURE-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN SURGICAL MESH MARKET SIZE, BY TACK-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 191. ASEAN SURGICAL MESH MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN SURGICAL MESH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN SURGICAL MESH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 194. GCC SURGICAL MESH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 195. GCC SURGICAL MESH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. GCC SURGICAL MESH MARKET SIZE, BY ABSORBABLE MESH, 2018-2032 (USD MILLION)
  • TABLE 197. GCC SURGICAL MESH MARKET SIZE, BY NON-ABSORBABLE MESH, 2018-2032 (USD MILLION)
  • TABLE 198. GCC SURGICAL MESH MARKET SIZE, BY FIXATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 199. GCC SURGICAL MESH MARKET SIZE, BY ADHESIVE-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 200. GCC SURGICAL MESH MARKET SIZE, BY SUTURE-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 201. GCC SURGICAL MESH MARKET SIZE, BY TACK-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 202. GCC SURGICAL MESH MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. GCC SURGICAL MESH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 204. GCC SURGICAL MESH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPEAN UNION SURGICAL MESH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPEAN UNION SURGICAL MESH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPEAN UNION SURGICAL MESH MARKET SIZE, BY ABSORBABLE MESH, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPEAN UNION SURGICAL MESH MARKET SIZE, BY NON-ABSORBABLE MESH, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION SURGICAL MESH MARKET SIZE, BY FIXATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPEAN UNION SURGICAL MESH MARKET SIZE, BY ADHESIVE-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPEAN UNION SURGICAL MESH MARKET SIZE, BY SUTURE-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPEAN UNION SURGICAL MESH MARKET SIZE, BY TACK-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPEAN UNION SURGICAL MESH MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPEAN UNION SURGICAL MESH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPEAN UNION SURGICAL MESH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 216. BRICS SURGICAL MESH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 217. BRICS SURGICAL MESH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. BRICS SURGICAL MESH MARKET SIZE, BY ABSORBABLE MESH, 2018-2032 (USD MILLION)
  • TABLE 219. BRICS SURGICAL MESH MARKET SIZE, BY NON-ABSORBABLE MESH, 2018-2032 (USD MILLION)
  • TABLE 220. BRICS SURGICAL MESH MARKET SIZE, BY FIXATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 221. BRICS SURGICAL MESH MARKET SIZE, BY ADHESIVE-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 222. BRICS SURGICAL MESH MARKET SIZE, BY SUTURE-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 223. BRICS SURGICAL MESH MARKET SIZE, BY TACK-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 224. BRICS SURGICAL MESH MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. BRICS SURGICAL MESH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 226. BRICS SURGICAL MESH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 227. G7 SURGICAL MESH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 228. G7 SURGICAL MESH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. G7 SURGICAL MESH MARKET SIZE, BY ABSORBABLE MESH, 2018-2032 (USD MILLION)
  • TABLE 230. G7 SURGICAL MESH MARKET SIZE, BY NON-ABSORBABLE MESH, 2018-2032 (USD MILLION)
  • TABLE 231. G7 SURGICAL MESH MARKET SIZE, BY FIXATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 232. G7 SURGICAL MESH MARKET SIZE, BY ADHESIVE-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 233. G7 SURGICAL MESH MARKET SIZE, BY SUTURE-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 234. G7 SURGICAL MESH MARKET SIZE, BY TACK-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 235. G7 SURGICAL MESH MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 236. G7 SURGICAL MESH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 237. G7 SURGICAL MESH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 238. NATO SURGICAL MESH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 239. NATO SURGICAL MESH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 240. NATO SURGICAL MESH MARKET SIZE, BY ABSORBABLE MESH, 2018-2032 (USD MILLION)
  • TABLE 241. NATO SURGICAL MESH MARKET SIZE, BY NON-ABSORBABLE MESH, 2018-2032 (USD MILLION)
  • TABLE 242. NATO SURGICAL MESH MARKET SIZE, BY FIXATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 243. NATO SURGICAL MESH MARKET SIZE, BY ADHESIVE-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 244. NATO SURGICAL MESH MARKET SIZE, BY SUTURE-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 245. NATO SURGICAL MESH MARKET SIZE, BY TACK-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 246. NATO SURGICAL MESH MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. NATO SURGICAL MESH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 248. NATO SURGICAL MESH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 249. GLOBAL SURGICAL MESH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 250. UNITED STATES SURGICAL MESH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 251. UNITED STATES SURGICAL MESH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 252. UNITED STATES SURGICAL MESH MARKET SIZE, BY ABSORBABLE MESH, 2018-2032 (USD MILLION)
  • TABLE 253. UNITED STATES SURGICAL MESH MARKET SIZE, BY NON-ABSORBABLE MESH, 2018-2032 (USD MILLION)
  • TABLE 254. UNITED STATES SURGICAL MESH MARKET SIZE, BY FIXATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 255. UNITED STATES SURGICAL MESH MARKET SIZE, BY ADHESIVE-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 256. UNITED STATES SURGICAL MESH MARKET SIZE, BY SUTURE-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 257. UNITED STATES SURGICAL MESH MARKET SIZE, BY TACK-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 258. UNITED STATES SURGICAL MESH MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 259. UNITED STATES SURGICAL MESH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 260. UNITED STATES SURGICAL MESH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 261. CHINA SURGICAL MESH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 262. CHINA SURGICAL MESH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 263. CHINA SURGICAL MESH MARKET SIZE, BY ABSORBABLE MESH, 2018-2032 (USD MILLION)
  • TABLE 264. CHINA SURGICAL MESH MARKET SIZE, BY NON-ABSORBABLE MESH, 2018-2032 (USD MILLION)
  • TABLE 265. CHINA SURGICAL MESH MARKET SIZE, BY FIXATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 266. CHINA SURGICAL MESH MARKET SIZE, BY ADHESIVE-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 267. CHINA SURGICAL MESH MARKET SIZE, BY SUTURE-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 268. CHINA SURGICAL MESH MARKET SIZE, BY TACK-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 269. CHINA SURGICAL MESH MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 270. CHINA SURGICAL MESH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 271. CHINA SURGICAL MESH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)